TRxADE Health (NASDAQ: MEDS), a parent company of pharmaceutical business-to-business (“B2B”) exchange platform, and Scienture Inc., a wholly owned subsidiary of TRxADE, have announced a name change. According to the announcement, TRxADE is changing its name to Scienture Holdings Inc. The change is effective beginning Sept. 23, 2024; company stock will also begin trading on the NASDAQ exchange under a new ticker symbol — SCNX — that same day.
To view the full press release, visit https://ibn.fm/N3XEV
About TRxADE Health Inc.
TRxADE Health historically focused on health services IT assets and operations aimed at digitalizing the retail pharmacy experience. The company’s current primary operations are conducted through its wholly owned subsidiary, Integra Pharma Solutions (“IPS”), which is a licensed pharmaceutical wholesaler that sells brand, generic and nondrug products to customers. IPS customers include all healthcare markets including government organizations, hospitals, clinics and independent pharmacies nationwide. Scienture LLC is a New-York-based branded, specialty pharmaceutical company. The company is led by a highly experienced team of industry professionals who are passionate about developing unique specialty product concepts and solutions that bring enhanced value to patients and healthcare systems. Company assets in development are across therapeutics areas, indications and cater to different market segments. For more information about the company, please visit www.TRxADE.com and www.RXIntegra.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About TinyGems
TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.TinyGems.com
Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer
TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com
TinyGems is powered by IBN